Atlas Trials

A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia

Clinical trial NCT03934099 · COMPLETED

Trial details

NCT number
NCT03934099
Sponsor
LG Chem
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GoutHyperuricemia
Start date
2019-12-02
Primary completion
2021-05-03
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.